Annual Drug Patent Expirations for VIMOVO
Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for VIMOVO.
This drug has forty-nine patent family members in twenty-four countries.
The generic ingredient in VIMOVO is esomeprazole magnesium; naproxen. Two suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium; naproxen profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
